UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N -[(1 S ,2 S )-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents

The Journal of pharmacology and experimental therapeutics, 2007-06, Vol.321 (3), p.1013-1022

2007

Volltextzugriff (PDF)

Notch Inhibition of E47 Supports the Existence of a Novel Signaling Pathway

Molecular and Cellular Biology, 1998-04, Vol.18 (4), p.2230-2239

1998

Volltextzugriff (PDF)

Miranda is required for the asymmetric localization of Prospero during mitosis in Drosophila

Cell, 1997-08, Vol.90 (3), p.449-458

1997

Volltextzugriff (PDF)

B-cell-specific DNA binding by an E47 homodimer

Molecular and Cellular Biology, 1995-08, Vol.15 (8), p.4518-4524

1995

Volltextzugriff (PDF)

The role of melanocortins in body weight regulation: opportunities for the treatment of obesity

European journal of pharmacology, 2002-08, Vol.450 (1), p.93-109

2002

Volltextzugriff (PDF)

Synthesis and evaluation of N-[(1 S,2 S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (17), p.5195-5199

2009

Volltextzugriff (PDF)

Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

Journal of medicinal chemistry, 2006-12, Vol.49 (26), p.7584-7587

2006

Volltextzugriff (PDF)

The role of melanocortins in body weight regulation: opportunities for the treatment of obesity

European journal of pharmacology, 2002-04, Vol.440 (2), p.141-157

2002

Volltextzugriff (PDF)

Phosphorylation of E47 as a potential determinant of B-cell-specific activity

Molecular and Cellular Biology, 1996-12, Vol.16 (12), p.6900-6908

1996

Volltextzugriff (PDF)

Conformational Analysis and Receptor Docking of N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (Taranabant, MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2108-2114

2008

Volltextzugriff (PDF)

Discovery of N -[(4 R )-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2 H -pyrano[2,3- b ]pyridin-4-yl]-5-methyl-1 H -pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity

Journal of medicinal chemistry, 2010-05, Vol.53 (10), p.4028-4037

2010

Volltextzugriff (PDF)

Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells

Brain research, 2008-10, Vol.1238, p.36-43

2008

Volltextzugriff (PDF)

Furo[2,3- b]pyridine-based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Part 1

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (4), p.1448-1452

2010

Volltextzugriff (PDF)

Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice

Brain research, 2004-03, Vol.999 (2), p.227-230

2004

Volltextzugriff (PDF)

Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabant

Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (16), p.4757-4761

2010

Volltextzugriff (PDF)

Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation

Bioorganic & medicinal chemistry letters, 2010-06, Vol.20 (12), p.3750-3754

2010

Volltextzugriff (PDF)

Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation

Bioorganic & medicinal chemistry letters, 2009-05, Vol.19 (9), p.2591-2594

2009

Volltextzugriff (PDF)

Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development

Molecular and Cellular Biology, 1991-12, Vol.11 (12), p.6185-6191

1991

Volltextzugriff (PDF)

Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists

Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (5), p.1441-1446

2005

Volltextzugriff (PDF)

F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist

European journal of pharmacology, 2006-02, Vol.531 (1-3), p.41-46

2006

Volltextzugriff (PDF)

Miranda as a multidomain adapter linking apically localized Inscuteable and basally localized Staufen and Prospero during asymmetric cell division in Drosophila

Genes & development, 1998-06, Vol.12 (12), p.1837-1846

1998

Volltextzugriff (PDF)

Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.645-651

2005

Volltextzugriff (PDF)

Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists

Bioorganic & medicinal chemistry letters, 2007-04, Vol.17 (8), p.2184-2187

2007

Volltextzugriff (PDF)

Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists

Bioorganic & medicinal chemistry letters, 2006-02, Vol.16 (3), p.681-685

2006

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(43)
Dissertationen
(1)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Animals
(29)
Humans
(22)
Biological And Medical Sciences
(21)
Pharmacology & Pharmacy
(20)
Medical Sciences
(19)
Pharmacology. Drug Treatments
(19)
Chemistry, Medicinal
(14)
Mice
(12)
Miscellaneous
(12)
Neuropharmacology
(12)
Neurotransmitters. Neurotransmission. Receptors
(12)
Obesity
(12)
Rats
(12)
Receptor, Cannabinoid, Cb1 - Agonists
(11)
Structure-Activity Relationship
(11)
Cannabinoid
(9)
Chemistry
(9)
Chemistry, Organic
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N -[(1 S ,2 S )-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents

Notch Inhibition of E47 Supports the Existence of a Novel Signaling Pathway

Miranda is required for the asymmetric localization of Prospero during mitosis in Drosophila

B-cell-specific DNA binding by an E47 homodimer

The role of melanocortins in body weight regulation: opportunities for the treatment of obesity

Synthesis and evaluation of N-[(1 S,2 S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists

Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

The role of melanocortins in body weight regulation: opportunities for the treatment of obesity

Phosphorylation of E47 as a potential determinant of B-cell-specific activity

Conformational Analysis and Receptor Docking of N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (Taranabant, MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist

Discovery of N -[(4 R )-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2 H -pyrano[2,3- b ]pyridin-4-yl]-5-methyl-1 H -pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity

Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells

Furo[2,3- b]pyridine-based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Part 1

Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice

Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabant

Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation

Discovery of N-{(1S,2S)-2-(3-Cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a Cannabinoid-1 Receptor Positron Emission Tomography Tracer Suitable for Clinical Use

Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation

Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development

Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists

F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist

Miranda as a multidomain adapter linking apically localized Inscuteable and basally localized Staufen and Prospero during asymmetric cell division in Drosophila

Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists

Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists

Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists

Suchergebnisse filtern